Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients. (COINN)

March 27, 2023 updated by: Masaryk University

Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients. Effect on Energy and Protein Target Achievement, Tolerance and Incidence of Complications. Monocentric Prospective Randomised Study.

The purpose of the study is to compare continuous versus intermittent strategy for enteral nutrition. The study will examine if there is a difference in achieving nutritional delivery goals, tolerance and number of complications of enteral nutrition.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The study will commence following the Approval by The Ethics Research Committee. All patients admitted to our ICU from the 1st of June 2018 to the 31st of May 2019 will be enrolled after fulfilling the inclusion criteria and in the absence of any exclusion criteria. Informed consent will be requested. Enteral nutrition will be administered via nasogastric of orogastric tube. Patients will be randomised in 2 groups. In the group of patients receiving continuous feeding will be enteral nutrition administered via enteral feeding pump for at least 16 hours par day. In the group of patients receiving intermittent feeding will be enteral nutrition administered as 30-60minutes lasting bolus via enteral feeding pump 6 times per day. Following the administration of the bolus the patient will be placed for 30 minutes in semi-upright sitting position. Enteral nutrition requirement and composition will be standardised with the adoption of international guidelines. In 5 subsequent days from the enteral nutrition commencement will be examined if there is a difference in achieving energy and protein targets, tolerance and number of complications of enteral nutrition in between both groups. As achievement of energy and protein targets will be considered at least 80% of calculated values. The tolerance of enteral nutrition will be evaluated by the clinical examination of the abdomen, presence of diarrhoea, vomiting and the gastric residual volume of at least 0,5 liter. As the complications of enteral nutrition will be regarded the aspiration of gastric contents and ventilator associated pneumonia. Nutritional status parameters will be analysed. the length of hospital stay, ICU length of stay and 28-day mortality will be also monitored.

Study Type

Interventional

Enrollment (Anticipated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brno, Czechia, 62500
        • Recruiting
        • University Hospital Brno and Masaryk University Brno

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age between 18 - 80 years
  • indication of enteral nutrition with nasogastric or orogastric tube
  • Nutrition Risk in the Critically Ill (NUTRIC) score ≥5
  • Body mass index between 18 - 50
  • mechanical ventilation expected for at least 72 hours

Exclusion Criteria:

  • upper gastrointestinal tract surgery in previous medical history
  • bowel obstruction
  • bowel ischemia
  • acute pancreatitis
  • severe diarrhoea (>1l/24hours)
  • gastrointestinal bleeding
  • short bowel syndrome
  • malabsorption syndrome in previous medical history
  • ongoing enteral nutrition on admission to ICU

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intermittent
enteral nutrition will be administered via enteral feeding pump as 30-60minutes lasting bolus 6 times per day volume of initial bolus will be 80ml. The volume of bolus will be increased gradually according to tolerance, till the estimated target rate will be reached
administration of enteral nutrition
Experimental: Continuous
enteral nutrition will be administered via enteral feeding pump for at least 16 hours par day initial rate will be 25ml/hour. The rate will be increased gradually according to tolerance, till the estimated target rate will be reached
administration of enteral nutrition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Energy target
Time Frame: 5 days from initiation of enteral nutrition
Daily assessment of energy intake in critically ill patients with enteral nutrition.Energy target will be achieved if at least 80% of calculated energy intake will be delivered.
5 days from initiation of enteral nutrition

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protein target
Time Frame: 5 days from initiation of enteral nutrition
Daily assessment of protein intake in critically ill patients with enteral nutrition.Protein target will be achieved if at least 80% of calculated protein intake will be delivered.
5 days from initiation of enteral nutrition
Tolerance of enteral nutrition
Time Frame: 5 days from initiation of enteral nutrition
Measurement of the gastric residual volume
5 days from initiation of enteral nutrition
Tolerance of enteral nutrition
Time Frame: 5 days from initiation of enteral nutrition
Incidence of diarrhoea
5 days from initiation of enteral nutrition
Tolerance of enteral nutrition
Time Frame: 5 days from initiation of enteral nutrition
Incidence of vomiting
5 days from initiation of enteral nutrition
Complications of enteral nutrition
Time Frame: 5 days from initiation of enteral nutrition
Incidence of aspiration and ventilator associated pneumonia
5 days from initiation of enteral nutrition
Nutritional status
Time Frame: On admission and day 5 from initiation of enteral nutrition
Blood test : total serum protein test
On admission and day 5 from initiation of enteral nutrition
Nutritional status
Time Frame: On admission and day 5 from initiation of enteral nutrition
Blood test : albumin test
On admission and day 5 from initiation of enteral nutrition
Nutritional status
Time Frame: On admission and day 5 from initiation of enteral nutrition
Blood test : prealbumin test
On admission and day 5 from initiation of enteral nutrition

Other Outcome Measures

Outcome Measure
Time Frame
ICU and hospital length of stay
Time Frame: through study completion, an average of 3 weeks
through study completion, an average of 3 weeks
28-day mortality
Time Frame: 28 days from randomisation
28 days from randomisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2018

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

April 17, 2018

First Submitted That Met QC Criteria

June 19, 2018

First Posted (Actual)

June 29, 2018

Study Record Updates

Last Update Posted (Actual)

March 28, 2023

Last Update Submitted That Met QC Criteria

March 27, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CT0012018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nutrition Disorders

Clinical Trials on enteral nutrition

3
Subscribe